Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?

Cerebrovascular Diseases

Volumn 11, Issue 1, 2001, Pages 30-33

  Stingele, Robert ^a   Bluhmki, E ^b   Hacke, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Clinical Research and Statistics   (Germany)

Author keywords

Acute ischaemic stroke; Bootstrap statistics; ECASS II; Thrombolysis

Indexed keywords

ALTEPLASE;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICS;

CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; RESEARCH DESIGN; STATISTICS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035139213     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047608     Document Type: Article

References (5)

1. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
2. An introduction to the bootstrap
3. Tissue plasminogen activactor for acute ischaemic stroke
4. Dichotomized efficacy end points and gobal end point analysis applied to the ECASS intention-to-treat- data set: Post hoc analysis of ECASS
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke